Role of Biologics and Other Therapies in Stricturing Crohn’s Disease: What Have We Learnt So Far?

Publisher： Karger

E-ISSN： 1421-9867|77|1|38-47

ISSN： 0012-2823

Source： Digestion, Vol.77, Iss.1, 2008-02, pp. : 38-47

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

What Options Do We Have for Induction Therapy for Crohn’s Disease?

By  

Digestive Diseases, Vol. 28, Iss. 3, 2010-09 ,pp. : 543-547

Karger

Access to resources Recommend Favorite

Have We Changed the Natural History of Pediatric Crohn's Disease with Biologics?

By  

Digestive Diseases, Vol. 32, Iss. 4, 2014-06 ,pp. : 360-363

Karger

Access to resources Recommend Favorite

The Role of Antibiotics in Crohn’s Disease

By  

Digestive Diseases, Vol. 17, Iss. 1, 1999-07 ,pp. : 1-5

Karger

Access to resources Recommend Favorite

Disease-specific quality of life evaluation and its determinants in Cushing’s syndrome: what have we learnt?

By Badia X.   Valassi E.   Roset M.   Webb S.  

Pituitary, Vol. 17, Iss. 2, 2014-04 ,pp. : 187-195

Springer Publishing Company

Access to resources Recommend Favorite

Have Biologics Changed the Natural History of Crohn's Disease?

By  

Digestive Diseases, Vol. 32, Iss. 4, 2014-06 ,pp. : 351-359

Karger

Access to resources Recommend Favorite